M&A Deal Summary

West Coast Capital Acquires Ellipses Pharma

On July 7, 2023, family office West Coast Capital acquired life science company Ellipses Pharma

Acquisition Highlights
  • This is West Coast Capital’s 1st transaction in the Life Science sector.
  • This is West Coast Capital’s 6th transaction in the United Kingdom.

M&A Deal Summary

Date 2023-07-07
Target Ellipses Pharma
Sector Life Science
Buyer(s) West Coast Capital
Deal Type Buyout (LBO, MBO, MBI)

Target

Ellipses Pharma

London, United Kingdom
Ellipses Pharma develops new treatments for cancer that address unmet clinical need. Ellipses Pharma is based in London, United Kingdom.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

DESCRIPTION

West Coast Capital is a private investment firm focused on growth oriented investments in the retail, real estate, and technology sectors. The Firm looks to invest £5 to £20 million to support a variety of transaction situations. These include public to private transactions, venture capital investments, and growth capital financings. West Coast Capital was formed in 2001 and is based in Dundonald, England.


DEAL STATS #
Overall 7 of 7
Sector: Life Science M&A 1 of 1
Type: Buyout (LBO, MBO, MBI) M&A Deals 1 of 1
Country: United Kingdom M&A 6 of 6
Year: 2023 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-01 Buzzworks Holdings

Kilmarnock , United Kingdom

Buzzworks Holdings offers hospitaility services. Buzzworks Holdings is based in Kilmarnock, United Kingdom.

Buy -